·         Date of Birth: August 4, 1962

·         Marital Status: Married, two children

·         Spouse: Mr. Jeffrey King: Teacher

·         Citizenship: American Citizen

·         Board Certified, Hematology

·         Board Certified, Oncology

·         Board Certified, Internal Medicine

·         CA License # A72528

·         DEA # BR7188041

·         Fellowship: USC/Norris Hematology/Oncology 2001-2004

·         Residency: WLAVA/UCLA, Internal Medicine Program

·         First Residency/Hematology Fellow Training: Henan Medical University, Zhengzhou, Henan Province, P.R. China, 1985-1991

·         MD: Henan Medical University, Zhengzhou, Henan Province, P.R. China, 1980-1985

·         Received Best Student Awards (top 2%) in all five years of medical school

·         Second Place Presentation Award.  The Council on Geriatric Cardiology, Second Annual Scientific Session, 1996

·         Highest Achievement Award for Scientific Research of Henan Province, 1988

·         Advance Medical Training Scholarship, 1985-1988

·         Medical School Scholarship, 1980-1985

·         AMA Membership: 1998-2001

·         ASH Membership: 2002-Present

·         Associate 7/2005 – Present: California Hematology Oncology Medical Group.  6801 Park Terrace, Suite 130, Los Angeles, CA 90045

·         Associate 8/2004 – 5/2005: 1140 W. La Veta Ave, Suite 430, Orange, CA 90668

·         Fellowship Hematology/Oncology: 7/2001 – 6/2004: Department of Hematology/Oncology, USC/Norris

·         Residency, Internal Medicine: 7/1998 – 6/2001: Department of Medicine, WLA VA/UCLA

·         Clinical Research Associate 1994-1998: Gerontology Section, LB VAAMC, Department of Medicine, University of California, Irvine

·         Attending Physician 7/1991 – 1/1994: Department of Hematology, Second Teaching Hospital of Henan Medical University, Henan Province, P.R. China

·         Residency and Fellowship, Internal Medicine 7/1985 – 6/1991: Department of Hematology, Second Teaching Hospital of Henan Medical University, Henan Province, P.R. China

·         Postdoctoral Research Fellow/Clinical Research Associate, April 1995-1998: Gerontology Section, LB VAAMC, Department of Medicine, University of California, Irvine

·         Research during Hematology Fellowship 9/1985 - 7/1988: Department of Hematology, First Teaching Hospital of Henan Medical University, Henan Province, P.R. China.  Research activities: immunology, tissue and cell culture, molecular biology

·         Phase I Trial of I.V. Fenretinide in Patients with Malignant Solid Tumors

·         A Study to Compare the LDL-C lowering Efficacy of Pravastatin 40mg Administered Once Daily Versus a Divided Dosing Regimen

·         A Randomized, Double-Blind, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of BRL 49653C Administered to Patients with NIDDM who are Inadequately Controlled with Insulin Monotherapy

·         Lecturer 9/1988 – 1/1994: Department of Hematology, Henan Medical University, Henan Province, P.R. China

·         Family activities, reading, singing, swimming 

Original Papers and Books:

·         Ru, Jenny.  Liebman, Howard.  Successful Treatment of Refractory Pure Red Cell Aplasia Associated with Lymphoproliferative Disorders with the Anti-CD52 Monoclonal Antibody Alemtuzumab (Campath-1).  In press

Reviews:

·         Ru, XQ.  Xi, YR.  Natural Killer Cel and Hematology.  Chinese Journal of Western Medicine, Infusion and Hematology Edition, 1988; 3:177

·         Ru, XQ.  Xi, YR, et al.  Clinical Application of Interferon Alpha.  Chinese Journal of Western Medicine, Biology and Technology Edition, 1988

·         Ru, XQ.  Hepatitis B Virus DNA in Serum:  Applied Molecular Biology in the Evaluation of Hepatitis B Infection

Selective Abstracts:

·         Ru, J et al:  Hepatic intra-arterial infusion (HIA) of Cisplatin and mitomycin-c for hepatocellular carcinoma (HCC): The USC Experience.  Abstract # 1519: ASCO 2003

·         Ru, XQ. Studies on Mechanism of Biomolan Inducing Leukemia.  The Annual Meeting of South-Western District of the Society of Hematology, 1989

·         Ru, XQ.  The Signification of Determination of Sialic Acid in Patients with Leukemia.  Sixth FAOB Congress, 1992

·         Ru, XQ.  Xi, YR.  The Effectiveness of Combined Chemotherapy in fifty-six Patients with Leukemia.  Chinese Symposium of Hematology, 1993

·         Downey, NA.  Bailey, R.  Ru, XQ.  Kashyap, ML.  Hagar, JM.  Effectiveness of Lipid Lowering Therapy in Elderly Veterans with Coronary Artery Disease.  The American Journal of Geriatric Cardiology, 1996; 5: 57

·         Downey, NA.  Bailey, R.  Ru, XQ.  Kashyap, ML.  Hagar, JM.  Dyslipidemia in Elderly Veterans with Coronary Artery Disease: Current Status of Evaluation and Treatment.  The American Journal of Geriatric Cardiology, 1996; 5: 57